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Supraceliac Aortic Occlusion in Dogs With a Critical Coronary Stenosis 
Joyce A. Wahr, MD, Kim P. Gallagher, PhD, Alan R. Tait, PhD, Charles B. Hantler, MD, and Paul R. Knight, MD, PhD 
The hemodynamic consequences and myocardial blood flow 
alterations associated with cross-clamping of the thoracic 
aorta were studied during pentobarbital (control), halothane 
(1 MAC), and isoflurane (1 MAC) anesthesia in dogs with a 
critical stenosis of tho left circumflex coronary artery. Aortic 
clamping at the fevef of the diaphragm resulted in significant 
and equivalent increases in mean aortic pressure and left 
atrial pressure during the control clamp, halothane clamp, 
and isoflurane cfamp periods. Likewise, aortic clamping 
resulted in a signifkzmt and equivalent decrease in cardiac 
output during control-clamp, halothane clamp, and isoflu- 
rane clamp. Myocardial contractility as assessed by dP/dt 
was depressed during halothans and isoflurane anesthesia 
when compared with control, but no further change in 
S URGICAL REPAIR of aortic aneurysms or occlusive disease requires occlusion of the aorta above the site 
of repair. Clamping of the aorta in this manner increases 
left ventricular (LV) afterload and preload, thereby increas- 
ing wal1 tension and myocardial oxygen demands. Such 
elevations may also decrease coronary perfusion pressure 
in the subendocardium if the elevation in end-diastolic 
pressure in the LV outweighs the increase in mean aortic 
pressure. Because many patients undergoing peripheral 
vascular surgery also have significant coronary artery dis- 
ease (CAD), it is not surprising that aortic clamping has 
been associated with episodes of myocardial ischemia, 
dysrhythmias, and decreased cardiac output (CO).‘.’ The 
surgical mortality for such a procedure can be as high as 3% 
to 9%, and more than half of these deaths can be attributed 
to perioperative cardiac events.‘.’ 
Recent reports that link intraoperative myocardial is- 
chemia to the development of postoperative myocardial 
infarction emphasize the importante of anesthetic manage- 
ment that minimizes myocardial ischemia during high-risk 
operative procedures such as those involving aortic 
clamping? Myocardial ischemia occurs when the balance 
between oxygen supply and demand is inappropriate, either 
due to increased demand (increased wal1 tension, tachycar- 
dia) or decreased supply (limited coronary vasodilatation, 
decrease in perfusion pressure, inappropriate distribution 
of regional or transmural blood flow). The optimal anes- 
thetic would be one that limits hemodynamic changes 
(control increases in wal1 tension and/or tachycardia) with- 
out adversely affecting myocardial oxygen supply, either 
globally or regionally. One technique for controlling the 
hemodynamic changes due to aortic occlusion is the use of 
the volatile anesthetics halothane or isoflurane.‘“~” Halo- 
thane is known to reduce oxygen demand, but has negative 
contractility was associated with eortic clamping. NO signifi- 
cant alterations in regional or transmural myocardial blood 
flow were found with halothane or isoffurane anesthesia, or 
with aortic clamping during halothano or isoflurane anesthe- 
sia. It is concluded that there are signiffcant hemodynamic 
consequences associated with aortic clamping, that neither 
halothane nor isoflurane anesthesia alters these conse- 
quences when compared with pentobarbftal anesthesia alone, 
and that the deterioration in myocardial function observed 
during aortic clamping with halothane and isoflurane anesthe- 
sia cannot be attributed to any maldistribution of myocardial 
blood flow. 
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inotropic effects that may further increase LV end-diastolic 
pressure. ‘2-‘4 Isoflurane has known vasodilating effects and, 
thus, can preserve CO despite a negative inotropic effect 
similar to that noted with halothane.15 By reducing the 
increase in afterload associated with aortic clamping, isoflu- 
rane could decrease myocardial oxygen demand and tend to 
protect the myocardium from ischemic injury. However, 
isoflurane’s vasodilating effects could also jeopardize myo- 
cardial oxygen supply distal to coronary stenoses should a 
steal phenomenon occur.‘6.‘9 
In an attempt to find an anesthetic technique that 
protects the compromised heart from the deleterious ef- 
fects of aortic clamping, the hemodynamic and metabolic 
effects of isoflurane and halothane anesthesia were investi- 
gated during aortic clamping in dogs with a critical stenosis 
of a coronary artery. To determine the effect of these 
interventions on the transmural distribution of myocardial 
blood flow, the tracer-labeled radioactive microsphere 
technique was used. 
MATERIALS AND METHODS 
The protocol was approved by the Institutional Animal Care and 
Use Committee, and complied with the “Principles of Laboratory 
Animal Care” and the “Guide for the Care and Use of Laboratory 
Animals” (NIH Publication No. 80.23, revised 1978). Twenty-two 
mongrel dogs of either sex weighing between 18 and 25 kg were 
anesthetized witb pentobarbital (30 mg/kg, intravenously [IV]), 
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undetwent endotracheal intubation, and were ventilated to main- 
tain a PaCO, of 35 to 45 mm Hg. Sodium bicarbonate was 
administered throughout the procedure to correct any base deficit 
and maintain normal pH. NaCI, 0.9%, was administered to 
maintain a pulmonary capillary wedge pressure (PCWP) of 5 to 10 
mm Hg except during the periods of aortic cross-clamping. 
The left femoral and right carotid arteries were catheterized 
with tygon tubing (inner diameter, 0.04 mm) for simultaneous 
withdrawal of arterial samples during microsphere injection. Arte- 
rial blood pressure was measured with a Statham P23 Db trans- 
ducer (Gould, Akron, OH) connected to a catheter inserted into 
the right carotid artery. A pulmonary artery catheter was inserted 
via the right internal jugular vein to monitor pulmonaty artery 
pressure (PAP) and PCWP. CO was determined in triplicate at 
each measurement point by thermodilution using 10 mL of iced 
saline injected into the right atrium. A Millar high-fidelity microma- 
nometer catheter (model PC350, Houston, TX) was placed via the 
left carotid artery retrograde into the LV to measure LV pressures. 
The LV pressure signal was differentiated to continuously measure 
dP/dt. 
A left thoracotomy was performed through the fifth intercostal 
space and the heart was suspended in a pericardial cradle. A Tygon 
catheter was placed in the left atrium for measurement of left atria1 
pressure (LAP) and for injection of microspheres. The proximal 
left circumflex coronary artery (LCA) was dissected free and an 
electromagnetic flow probe (Pulsed-Logie Flow Meter, model 
BL610, Harvard Apparatus Co, South Natick, MA) was placed 
around it to measure coronary blood flow. A plastic screw clamp 
placed distal to the flow probe was used to narrow the coronary 
artery and induce a critical stenosis. A silk ligature was placed 
around the circumflex artery to produce intermittent 5second 
occlusions of the LCA that, when released, resulted in a reactive 
hyperemie response (Fig 1). Critical stenosis was defined as the 
degree of LCA narrowing that eliminated the reactive hyperemie 
response to a 5-second total occlusion without altering mean 
coronaty blood flow at rest.” 
Regional myocardial blood flow (MBF) was measured with 
tracer-labeled microspheres (15~urn in diameter; New England 
Nuclear, Billerica, MA) using the reference withdrawal method.“’ 
Four injections were made in each experiment, using one of six 
available isotopes (‘“‘Ce, “‘Sn, “Cr, ‘OSRu, “‘Nb, &Sc), chosen at 
random for each flow determination. Adequate dispersal of micro- 
spheres in their suspension (1 to 2 million microspheres per 
injection) was achieved by sonication for 30 minutes and vortex 
agitation for 5 minutes prior to injection into the left atrium. 
Fig 1. Cardiac schematic showing placement of 
monitoring catheters and instrumentation for cre- 
ation of critical stenosis. 
Reference arterial samples were obtained simultaneously from 
both femoral and carotid arteries at a constant rate (7.0 mL/min) 
with a Harvard withdrawal pump; withdrawals were initiated 
before microsphere injection and completed 2 minutes after 
injection. 
At the end of the experiments, the dogs were killed with IV KCI. 
The heart was removed and placed in formalin prior to sectioning. 
Multiple full-thickness sections were obtained in a standardized 
fashion around complete rings of the LV. Each black of tissue was 
divided into three sections of approximately equal thickness from 
endocardium to epicardium. The papillary muscles were discarded. 
The tissue samples were weighed and placed in counting vials for 
assay of radioactivity in a gamma scintillation counter (model 1185, 
GammaTrac, Elk Grove Village, IL). After correcting the counts in 
each tissue sample for background and overlapping counts with 
simultaneous equations, blood flow was calculated with the equa- 
tion? 
Qm = (Cm x Qr)/Cr 
where Qm, MBF in mlimin; Cm, counts/min in tissue samples; Qr, 
withdrawal rate of the reference arterial sample in mL/min; and 
Cr, counts/min in the reference arterial sample. Tissue flow 
(mL/min/g) was calculated by dividing flow by the weight of the 
appropriate sample. Background and overlap corrections and 
blood flow calculations were performed on an Apple Be microcom- 
puter (Cupertino, CA). To standardize the data analysis, the area 
of myocardium at the insertion of the posterior papillaxy muscle 
(perfused by the circumflex artery) was designated as the area at 
risk of ischemia, and the anterior wal1 myocardium (perfused by 
the left anterior descending coronary artety) was designated as 
normal. 
Hemodynamic parameters were recorded during each experi- 
ment on a six-Channel recorder (model 2600, Gould). Variables 
analyzed included MAP, mean PAP (mPAP), CO, heart rate 
(HR), LAP, systemic and pulmonary vascular resistance (SVR, 
PVR), LV dP/dt, and regional MBF. Hemodynamic and MBF data 
were analyzed at four time periods (control, control clamp, 
halothane or isoflurane, and halothane-clamp or isoflurane- 
clamp). In two dogs receiving halothane and in two dogs receiving 
isoflurane, the order of intetventions was reversed and these dogs 
were analyzed separately to determine whether order of interven- 
tion altered the response to the intervention. NO such influence 
was noted; therefore, al1 halothane-treated dogs and al1 isoflurane- 
treated dogs were analyzed in their respective groups. Statistical 
analysis was performed using paired t tests between groups and 
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Student’s t test within groups, and because multiple comparisons 
were performed, the Bonferroni inequality adjustment was used to 
correct the acceptable (Y leve1 for the number of comparisons.’ A 
probability leve1 of P < 0.05 (appropriately corrected with the 
Bonferroni inequality adjustment) was considered statistically 
significant. 
Thirty minutes were allowed for the dog to stabilize after 
completion of instrumentation. While recording control hemody- 
namic parameters, a control injection of microspheres was per- 
formed (CON). The descending thoracic aorta was then totally 
occluded just above the diaphragm with a nontraumatic vascular 
clamp. Following stabilization of blood pressure and LAP (5 to 10 
minutes after application of clamp), control-clamping hemody- 
namic measurements were performed and a second microsphere 
injection was made (CON CX). The vascular clamp was removed 
gradually to prevent declamping hypotension and 15 minutes were 
allowed for hemodynamic parameters to return to preclamping 
values (CO, HR, LAP, and MAP). The dog was then randomly 
assigned to receive halothane, 0.75% end-tidal concentration 
(n = 11) or isoflurane 1.25% end-tidal concentration (n = ll), as 
confirmed by mass spectrometry. After a stable end-tidal concentra- 
tion of inhaled agent was achieved (20 to 30 minutes), a third 
injection of microspheres was performed while recording hemody- 
namic measurements (ANES). The thoracic aorta was then oc- 
cluded as previously described, 5 to 10 minutes permitted for 
stabilization, and a fourth set of hemodynamic measurements and 
microsphere injection performed (ANES CX). Following comple- 
tion of al1 data collection, the dog was killed with an injection of 
KCl, and the heart and kidneys were removed for determination of 
blood flows. 
RESULTS 
Hemodynamic results are presented in Figs 2 to 5 and in 
Table 1. Mean arterial pressure (MAP) was lower during 
halothane and isoflurane when compared with control, and 
was lower during both halothane clamp and isoflurane 
clamp than during control clamp. MAP was not different 
with halothane anesthesia when compared with isoflurane 
anesthesia, either preclamp or during aortic clamping. 
Clamping of the supraceliac aorta caused a significant 
increase in MAP whether at control clamp, halothane 
clamp, or isoflurane clamp, and the magnitude of the 
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Fig 2. Change8 in mean aortic pressure associated with aortic 
clamping in dop recelving halothane (n = 11) and in dogs receiving 
iroflurane (n = 11). ??P 5 0.05, +*P á 0.01, +**P 5 0.001 vCON; ttp á 
0.001 Y ANES; OP 5 0.01 v CON CX. Values are given as mean * SIM 
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Fig 3. Alterations in CO associated with aortic clamping in dogs 
receiving halothane (n = 11) and in dogs receiving isoflurane (n = 11). 
??P i 0.01, ??*P I 0.001 “CON; tP % 0.01, ttp I 0.001 vANES. Values 
are given as mean + SEM. 
illustrated in Fig 2, actual MAP postaortic clamping was 
lower with halothane and isoflurane, but this lower MAP 
simply reflected a lower baseline MAP prior to aortic 
clamping and was not due to an alteration of the hemody- 
namic response to aortic clamping by halothane or isoflu- 
rane. Indeed, the hemodynamic response in MAP to aortic 
clamping was the same when halothane was compared with 
isoflurane. The increase in SVR associated with aortic 
clamping was the same during control-clamp, halothane- 
clamp, and isoflurane-clamp periods. There was no change 
in SVR associated with halothane or isoflurane anesthesia 
when compared either with control or with each other, and 
no differente in SVR between the anesthetics at aortic 
clamping. 
CO (Fig 3) was not altered during either halothane or 
isoflurane alone when compared with control, but was 
adversely affected by al1 periods of aortic clamping. The 
decrease in CO associated with aortic clamping was the 
same for control clamp, halothane clamp, and isoflurane 
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Fig 4. Changes in LAP associated with aortk clamping in dogs 
receiving halothane (n = 11) and in dogs receiving hoflurane (n = 11). 
??**P 5 0.001 “CON; tfJ I 0.01, ttP I 0.001 vANES. Values are given 
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Fig 5. Changes in dP/dt associated with aortic clamping in dogs 
receiving halothane (n = 11) and in dogs receiving isoflurane (n = 11). 
??*P 2 0.01, ??**P I 0.001 Y CON. Values are given as mean + SEM. 
control by either halothane or isoflurane anesthesia. Aortic 
clamping caused a significant, equivalent increase in LAP at 
control clamp, halothane clamp, and isoflurane clamp. The 
data on the first derivative of LV pressure are shown in Fig 
5. NO change was found in dP/dt preclamp to postclamp at 
any condition (control, halothane, or isoflurane), but a 
significant, equivalent decrease from control was found 
with both halothane and isoflurane. There was no further 
change in dP/dt associated with aortic clamping when 
halothane clamp or isoflurane clamp was compared with 
halothane or isoflurane. There were minimal changes in 
HR, and although some may have achieved statistical 
significante, there were no physiologically significant 
changes. 
Regional MBF results are shown in Fig 6 and Table 2; 
CIRC refers to myocardium in the region supplied by the 
narrowed circumflex artery and, thus, is the area at risk to 
develop ischemia (AT RISK); LAD refers to myocardium 
supplied by the unaffected left anterior descending artery 
and represents normal myocardium (NORMAL). MBF in 
the NORMAL zone (endocardium and epicardium) tended 
to be greater during isoflurane anesthesia than during 
halothane anesthesia when analyzed using a Student’s t 
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test; however, this differente was not significant once the 
Bonferroni correction for multiple comparisons was ap- 
plied. NO differente in MBF was noted in either the 
NORMAL or AT RISK region during either anesthetic 
when compared with control flow. There were no differ- 
ences in total flow or in flow distribution during aortic 
clamping among control, halothane, or isoflurane. NO 
alteration in MBF was noted transmurally. The endocardial: 
epicardial (Endo:Epi) ratio as shown in Fig 7 was greater 
than 1.0 in both regions at al1 measurement periods. There 
was no change in the Endo:Epi ratio observed at control 
clamp, halothane clamp, or isoflurane clamp, or the Endo: 
Epi ratio between isoflurane and halothane when com- 
pared with each other or control. 
DISCUSSION 
The most readily apparent conclusion to be drawn from 
the hemodynamic results is that halothane and isoflurane at 
1 MAC appear to have identical effects on MAP, SVR, CO, 
LAP, and dP/dt prior to or during high aortic clamping. In 
this model, there was no advantage of either anesthetic over 
the other or of either anesthetic over pentobarbitai by itself. 
Although a lower MAP was found during supraceliac 
clamping with halothane and isoflurane anesthesia, this 
lower MAP cannot be interpreted to indicate better myocar- 
dia1 performance than that observed with pentobarbital 
anesthesia alone. The elevations of SVR and LAP associ- 
ated with aortic clamping were not in any way attenuated 
with either isoflurane or halothane anesthesia. CO de- 
creased similarly at control-clamp, halothane-clamp, and 
isoflurane-clamp periods. In a clinical setting, reliance on a 
volatile agent such as halothane or isoflurane to lower MAP 
during high aortic clamping may provide a false sense of 
security where a “normal” MAP masks a significant deteri- 
oration in CO and a dangerous increase in LAP. It is stil1 
controversial whether every patient undergoing aortic clamp- 
ing requires monitoring with a pulmonary artery catheter, 
and in those cases done without the benefit of such a 
catheter, assessment of myocardial function is primarily 
based on MAP. Although a statement cannot be made as to 
the necessity of pulmonary arterial monitoring in every case 
Table 1. Hemodynamic Responses to Aortic Clamping 
MAP (mm Hg) LAP Imm Hg) CO lIJmin) SVR (dyne s. cm-“) dP/dt (mm Hg/s) HR (beatsimin) 
CON 131.70? 2.4 8.3 I 0.3 3.38 + 0.09 3,320 k 104 1.972 r 57 116 k 1.58 
CON CX 166.80 + 2.91 19.0 2 0.6* 2.25 + O.lOt 6,952 k 241* 1,999 + 81 119 f 1.90 
HAL 98.90 + 1.6* 7.1 + 0.2 2.91 + 0.09 2,947 + 106 1,180 +r 3l*t 106 + 1.241 
HAL CX 132.70 -+ 1.5tS 18.2 zk 0.7*t 1.76 + O.ll*t 7,296 r+ 282*t 1,162 2 42*t 113 +- 1.60 
CON 116.70 + 1.1 7.3 * 0.2 3.39 + 0.17 3,312 t 131 1,936 + 49 116 +- 2.40 
CON CX 159.20 + 1.8’ 22.5 -c 0.7* 2.06 + 0.14* 8,505 -t 403* 1,849 + 51 115 2 2.60 
ISO 96.36 + 1.85 9.7 2 0.4 2.71 2 0.13 3,334 k 127 1,195 + 31*t 110 -t 1.52 
ISO cx 132.60 + 1.5tS 18.6 f 0.6’t 1.75 + o.to*t 7,759 * 343*t 1,244 + 29*t 105 f 2.21 
NOTE. All values given as mean 2 SEM. 
Abbreviations: MAP, mean arterial pressure; LAP, leb atrial pressure; CO, cardiac output; SVR, systemic vascular resistance; dP/dt, contractility; 
HR. heart rate. 
??P < 0.01 Y control. 
tP < 0.01 v ANES. 
SP < 0.01 v CON CX. 
§P < 0.05 v control. 
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Fig 6. MBF at each.intervention. CIRC represents myocardium in the region supplied by the narrowed circumffex artery and, thur, is the area at 
risk for development of ischemia; LAD represents myocardium rupplied bv the unaffected left anterior descending artery. (A) Endocardiaf (ENDO) 
and eolcardial IEPI) flow in both reoions in dogs receiving halothane (n = 11). (B) Endocardial (ENDO) and epicardial (EPI) flow in both regions in 
dogs ieceivingisoffurane (n = 11). ialues are given as mean + SEM. 
involving aortic clamping, the present data demonstrate 
that, in this model, neither halothane nor isoflurane is 
capable of altering the increase in SVR and LAP and the 
deterioration in myocardial performance that may occur 
with supraceliac aortic clamping. 
The acute hemodynamic changes associated with suprace- 
liac aortic clamping fit the description given by Ross (based 
on initial work by Guyton) of afterload mismatch.*‘~z2 
Briefly, in any normal heart, there is an optimum match 
between LV filling volume/pressure (preload) and after- 
load. As afterload increases, incomplete emptying of the 
ventricle occurs, filling volume/pressure increases, and fiber 
length increases, allowing myocardial performance (mea- 
sured in this study by CO) to continue unchanged. Preload 
reserve is additional myocardial work that can be recruited 
by increases in fiber length. The limits of preload reserve 
are defined both by available venous return (determined by 
circulating blood volume, vascular tone) and by the point in 
any given heart where a further increase in fiber length 
leads to decreasing myocardial performance (descending 
limb of the Frank-Starling curve). If a given increase in 
afterload is not matched by an appropriate increase in 
preload, or if the preload reserve is exhausted, an afterload 
mismatch is created. The immediate consequente of such a 
mismatch is a decrease in stroke volume and, thus, a 
decrease in CO. Based on these results that show a 
dramatic increase in LAP and a decrease in CO during 
supraceliac clamping, it seems that such an afterload 
mismatch exists, due predominantly to exhaustion of pre- 
load reserve. In a canine model of aortic occlusion similar 
to the present one, Stokland et al” found that concurrent 
occlusion of the aorta and inferior vena cava effectively 
prevented any increase in preload, but caused CO to fa11 
much further than if preload was permitted to increase 
during aortic occlusion. Al1 these data support the concept 
that preload increases compensate for increased afterload, 
and that afterload mismatch can rapidly develop if the 
preload increase is limited or inappropriately matched to 
afterload. Once present, afterload mismatch can be attenu- 
ated or corrected by increasing the inotropic state of the 
myocardium. Such an increase in the inotropic state of the 
heart not only increases stroke volume and CO by increas- 
ing the velocity of myocardial fiber shortening, it also 
returns preload reserve by reducing LV end-diastolic vol- 
ume. In the present model, the dangers of halothane and 
isoflurane anesthesia are twofold: (1) these anesthetics do 
not alter the degree of afterload imposed by high aortic 
clamping (no change in SVR); and (2) they also reduce 
contractility (dP/dt) of the myocardium, potentially accentu- 
ating the mismatch between preload and afterload. 
Table 2. Regional Myocardiel Blood Flow During Aortic Clamping 
Endocardium tmUg/min) Epicsrdium tmUg/min) 









1.310 -t 0.062 
1.450 f 0.036 
0.922 + 0.026 
1.098 + 0.036 
1.440 ‘- 0.064 
1.790 r 0.053 
1.420 ? 0.062 
1.310 f 0.030 
1.210 + 0.056 
1.160 i 0.045 
0.870 r 0.020 
0.990 _t 0.023 
1.540 2 0.080 
1.790 + 0.052 
1.240 -c 0.054 
1.470 -t 0.054 
0.920 ? 0.036 
1.130 r 0.044 
0.766 ? 0.022 
0.850 f 0.030 
1.270 ? 0.084 
1.570 + 0.062 
1.340 f 0.071 
1.270 + 0.051 
1.180 2 0.083 
1.210 t 0.045 
0.839 2 0.029 
0.880 * 0.039 
1.260 rt 0.077 
1.290 * 0.050 
1.180 2 0.056 
1.180? 0.044 
NOTE. LAD denotes myocardium supplied by the unaffected LAD artery and represents normal tissue; CIRC is that tissue supplied by the stenosed 
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Fig 7. Transmural blood flow in dogs receiving halothane (n = 11) 
or isoflurane (n = 11). Note that the ratio of endocardfal blood flow to 
epicardial blood flow is greater than 1 at all time periods and in both 
regfons. CIRC HAL, myocardlum supplied by the narrowed circumflex 
artery in dogs receiving halothane; LAD HAL, myocardium supplied 
by the unaffected LAD artery in dogs receiving halothane; CIRC ISO, 
myocardium supplled by the narrowed circumflex attery in dogs 
recelvlng isoflurane; LAD ISO, myocardium supplied by the unaf- 
fected LAD artery in dogs receiving isoflurane. Values are given as 
mean + SEM. 
Isoflurane is generally believed to cause a dose-depen- 
dent decrease in SVR that preserves CO. The first such 
evidente of isoflurane’s effect on SVR came from studies in 
spontaneously breathing, healthy human volunteers, with- 
out surgical stimulation.24 Whereas the evidente that isoflu- 
rane does act as a dose-dependent peripheral vasodilator is 
clear, such an effect may not be apparent at the 1 MAC 
concentration when surgical stimulation is present, as in 
this model. Studies in which isoflurane at concentrations of 
0.5% to 2% did not reduce SVR have included work done 
on larnbsz hypertensive rats,26 dogs,27,28 and humans.29,3” 
Based on the present data and similar data from other 
laboratories, the clinical practitioner should not rely on 
isoflurane at this concentration to invariably decrease SVR, 
especially when the elevated vascular resistance is due to 
aortic clamping. 
NO alterations in MBF or its transmural distribution 
during either halothane or isoflurane anesthesia were 
found that could be construed as being likely to impair 
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myocardial performance. Certainly, the deleterious etIccts 
of aortic clamping on CO cannot be attributed to a 
redistribution in blood flow caused by either of these 
volatile anesthetics. No differente in MBF was noted 
between the region supplied by a vessel with a critical 
stenosis versus that supplied by a normal vessel. However, 
this experiment was not designed to specifically investigate 
coronary steal, and did not include either of thc key 
features felt to be important in the genesis of redistribution. 
Although there is some indication in the results that 
isoflurane may act as a coronary artery vasodilator, the 
vasodilation did not cause maldistribution of blood flow in 
this model with a single stenotic coronary artery. Although 
there was no evidente of blood flow redistribution, there 
was some indication of an increase in total LV blood flow 
similar to that demonstrated by Carson et al.” Different 
results may have been obtained had the coronary stenosis in 
this model been more severe. Not addressed by this 
experimental protocol is the question of whether any 
degree of myocardial ischemia was present, regionally or 
globally. Wal1 motion or segmental wal1 thickcning, or 
epicardial electrocardiographic tracings were not moni- 
tored. In this model, aortic cross-clamping elevated both 
mean aortic pressure and LV end-diastolic pressure, but it 
cannot be stated that in any given region (subendocardium 
v epicardium, normal v at risk) myocardial oxygen supply 
did or did not match oxygen demand. Nonetheless, because 
al1 measured hemodynamic parameters and myocardial 
blood flow determinants were equivalent among control, 
halothane, and isoflurane, it seems reasonable to conclude 
that any imbalance between myocardial oxygen supply and 
demand would have been equivalent with each agent. 
In conclusion, it was found that supraceliac aortic clamp- 
ing in dogs with a critical coronary stenosis resulted in 
similar hemodynamic consequences during both halothane 
and isoflurane anesthesia, and that both volatile agents may 
potentiate an afterload-preload mismatch that results from 
aortic clamping. Isoflurane did not alter SVR, nor result in 
better preservation of CO, when compared with either 
halothane or pentobarbital. In addition, no evidente of 
regional or transmural alterations in MBF was found in 
comparing isoflurane with halothane or pentobarbital ei- 
ther prior to or during high aortic cross-clamping. 
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